Fortress Biotech Inc
Fortress Biotech Inc (FBIO) Option Chain
Read more
Tracking the FBIO option chain helps you see every strike and expiry on Fortress Biotech Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of FBIO options activity at a glance. Use our scanner to monitor the FBIO option chain in real time and filter for the trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For FBIO stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where FBIO options are being actively traded, and where they are not.
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; and Accutane capsules for severe recalcitrant nodular acne. It also develops late stage product candidates, such as intravenous Tramadol for the treatment of post-operative acute pain; CUTX-101, an injection for the treatment of Menkes disease; MB-107 and MB-207 for the treatment of X-linked severe combined immunodeficiency; Cosibelimab for metastatic cancers; CK-101 for the treatment of patients with EGFR mutation-positive NSCLC; CAEL-101 for the treatment of amyloid light chain amyloidosis; Triplex vaccine for cytomegalovirus; and CEVA101 for the treatment of severe traumatic brain injury in adults and children.
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 91.17 | 104 | 0 | 0.10 | 0.00 | — | 0.10 | 2.50 | +32.98 | — | 1.30 | 0.62 | 0.68 | 0 | 44 | 8.83 |
| 100.00 | 7 | 0 | 0.25 | 0.00 | — | 0.25 | 5.00 | +165.96 | 2.30 | 3.90 | 3.12 | -0.02 | 0 | 0 | 0.00 |
| 100.00 | 0 | 0 | 4.90 | 0.00 | — | 4.90 | 7.50 | +298.94 | 3.10 | 7.10 | 5.62 | -0.52 | 0 | 0 | 0.00 |
As of Nov 13, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV Rank53.17% Moderate
- Market cap (M$)63
- 52 weeks high-58.50%
- 52 weeks low5.03%
- Analyst recommendationStrong Buy
1.00 - Target price$5.00
165.96% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-13
- P/E0.71
- Future P/E—
- EPS (ttm)2.66
- EPS growth next 5 years—
As of Nov 13, 2026